SCH-50911

SCH-50911 is a drug that acts as a GABA antagonist, specifically at GABA_B receptors. It was the first selective GABA_B antagonist to be discovered and researched. SCH-50911 has been used in the research of various types of pharmacology and neurology, including studies of epilepsy, anxiety, depression, and drug addiction.

Pharmacology

SCH-50911 is a GABA_B receptor antagonist. It works by blocking the action of the neurotransmitter GABA on GABA_B receptors. This results in an increase in the release of other neurotransmitters, such as dopamine and serotonin, which can have various effects on the body and brain.

Uses

SCH-50911 has been used in research to study the role of GABA_B receptors in various conditions. These include epilepsy, where it has been found to reduce the frequency and severity of seizures; anxiety, where it has been found to have anxiolytic effects; depression, where it has been found to have antidepressant effects; and drug addiction, where it has been found to reduce the rewarding effects of addictive drugs.

Side Effects

As with all drugs, SCH-50911 can have side effects. These can include nausea, vomiting, dizziness, and headache. However, these side effects are generally mild and temporary.

See Also

• GABA_B receptor
• GABA
• Neurotransmitter
• Pharmacology
• Neurology

SCH-50911 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia